NTLA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Intellia Therapeutics, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!
Portfolio Pulse from
A class action lawsuit has been filed against Intellia Therapeutics, Inc. and certain officers for alleged violations of federal securities laws. The lawsuit covers those who acquired Intellia securities between July 30, 2024, and January 8, 2025.
March 13, 2025 | 11:15 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Intellia Therapeutics is facing a class action lawsuit for alleged securities law violations, potentially impacting its stock price negatively in the short term.
The announcement of a class action lawsuit against Intellia Therapeutics for alleged securities violations is likely to create negative sentiment among investors, potentially leading to a short-term decline in stock price. Legal issues can raise concerns about the company's governance and financial stability.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100